BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2004
View Archived Issues
Exelixis makes significant progress in expanding and advancing development pipeline during Q1
Read More
Nuvelo expands pipeline to three cardiovascular candidates
Read More
Nektar Therapeutics reports positive developments on late-stage programs
Read More
Effective wound healing by topical application of novel preclinical therapeutic peptides
Read More
Leptin accelerates wound angiogenesis in vivo
Read More
Latest phase III data on exenatide in type 2 diabetes presented at ADA
Read More
Tripep receives approval to conduct alphaHGA microdosing study
Read More
Wyeth reviews R&D pipeline
Read More
MDI-based insulin regimen is more cost-effective than CSII
Read More
Successful islet cell transplantation using the Edmonton protocol
Read More
CV Therapeutics and FDA agree on Ranexa study protocol
Read More
Positive phase III results for Aryplase in MPS VI
Read More
Solvay reviews bifeprunox development
Read More
V.I. Technologies to merge with Panacos
Read More
New phase II study of ABT-874 for MS
Read More
Iconix to provide advanced chemogenomic profiling services to AstraZeneca
Read More
Data on intratumoral injection of INGN-241 in advanced cancer patients
Read More
Trillium Therapeutics inlicenses cytokine receptor antagonist program
Read More
Enrollment completed in CONFIRM 1 study of PTK/ZK for colorectal cancer
Read More
Clofarabine NDA accepted for priority review
Read More
Strattera receives U.K. approval
Read More
LL-37 demonstrates angiogenic activity in vitro
Read More
Cannabinoid receptor partial agonist with antihyperalgesic and antiallodynic effects in vivo
Read More
SD-208 shows promise in models of pulmonary fibrosis
Read More
Losartan reduces lung injury in preclinical studies
Read More
Gilead claims new HIV integrase inhibitors
Read More
New bone resorption inhibitors targeting OCIF presented by Sankyo
Read More
Novel GAL3 antagonists and their use in depression and anxiety treatment
Read More
New hypoglycemic agents developed by Yissum and Hadasit researchers
Read More
Sumitomo patent covers novel agents for use in autoimmune diseases
Read More
New dopaminergic and serotonergic agents identified at ProteoSys
Read More